In Our View: Good for Greenup
UK-KDMC announced an important expansion in Greenup County. In addition to upgrading its office complex in Bellefonte, UKKD will also build an urgent care center in Greenup County.
Many readers are aware that UK King's Daughters relocated some of its offices to the former Ashland Oil building. If not for King's Daughters, there's a decent chance both of those buildings would be empty.
Bellefonte Hospital utilized one of the buildings for some of its services. After Bellefonte exited our area, that resulted in concern about occupancy of those buildings.
UKKD has been hitting on all cylinders since the hospital merged with the University of Kentucky.
The new multimillion-dollar emergency department on the main campus will be open sometime this year. Of course, none of us want to visit an emergency room. The new state of the emergency room is desperately needed due to increased admissions and space limitations in the existing emergency department.
UKKD used careful planning in the construction of the new emergency department. The city worked well with hospital officials for necessary street closures. The Ashland campus has grown over the last few decades, offering many more services than in the past. Fortunately, they absorbed most of the business from the former Bellefonte Hospital.
Expanding health care in Greenup County is an important component for any area wishing to grow. Too many Greenup Countians have died in the back of ambulances trying to get to the emergency room. Having access to health care is essential for the well-being of any residence.
Some Greenup Countians use Portsmouth for their medical needs. KDMC has expanded into the Portsmouth area with a newer facility in the west end of Portsmouth.
For too long, those living in rural parts of Kentucky didn't have access to health care. It's still a problem in some parts of the Commonwealth. Greenup County deserves this. UKKD is delivering health care to an area in need.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
2 hours ago
- Medscape
Fast Five Quiz: Ovarian Cancer Overview
Ovarian cancer poses a significant threat to women's health, often developing quietly and without early symptoms. It is commonly discovered after progression. This late detection, along with resistance to treatment and frequent relapse, contributes to poor outcomes. Although medical and surgical interventions have evolved, survival rates remain low. These challenges highlight the critical importance of early detection methods, precise diagnostic technologies, and individualized care coordinated across medical specialties. How much do you know about ovarian cancer? Test your knowledge with this quick quiz. High-grade serous carcinoma is by far the most prevalent, representing approximately 70%-80% of epithelial ovarian cancer cases. In contrast, the low-grade form of serous carcinoma is much less common (< 5%). Endometrioid and clear cell subtypes are each responsible for about 10% of cases and have known associations with endometriosis. Mucinous carcinomas are uncommon, comprising a small fraction (around 3%) of epithelial ovarian cancers. Learn more about ovarian cancer. According to the National Institute for Health and Care Excellence guidelines, for patients with inherited mutations linked to a higher chance of developing ovarian cancer (eg, alterations in BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 ), the most effective preventive surgical procedure is the bilateral salpingo-oophorectomy (which is the removal of both fallopian tubes and ovaries). This intervention has been proven to greatly reduce ovarian cancer risk and enhance long-term survival among these high-risk groups. However, when performed in premenopausal women, it induces menopause. Removing one ovary (unilateral oophorectomy) or the uterus (total hysterectomy) does not offer adequate protection against ovarian cancer. Procedures like cervical conization are unrelated to ovarian cancer and are used to manage cervical abnormalities. Learn more about salpingo-oophorectomy. HRT is typically recommended for women who undergo bilateral salpingo-oophorectomy before reaching the natural age of menopause and have not had breast cancer. This type of surgery causes a sudden and early drop in estrogen levels, which can result in bothersome symptoms and increase the risk for long-term health issues such as bone loss or cardiovascular problems. HRT helps ease these effects and maintain health until the typical menopausal age. In contrast, women older than age 50 years are often already in or near menopause, and HRT is not routinely needed unless specific symptoms arise. Patients who have a history of breast cancer must be assessed on a case-by-case basis because HRT might not be safe. Women with a uterus should be offered combined HRT, whereas women without a uterus should be offered estrogen-only HRT. Additionally, women who have not had their ovaries removed do not experience the abrupt hormonal shift that warrants preventive HRT. Learn more about HRT. Individuals who carry a BRCA1 mutation face a significantly elevated risk of developing ovarian cancer, often at a younger age than those with other hereditary mutations. If a woman with a BRCA1 mutation decides not to undergo surgery to remove her ovaries and fallopian tubes, monitoring for early signs of cancer should begin after age 35 years. This timing aligns with evidence suggesting that BRCA1 -related ovarian cancers tend to occur earlier than those linked to BRCA2 or other genetic variants. Initiating surveillance at age 30 years is generally premature and not part of standard recommendations. For BRCA2 carriers, screening is usually deferred until after age 40 years, whereas those with alterations in genes like RAD51C, RAD51D, BRIP1 , or PALB2 typically begin surveillance after age 45 years. Individuals with Lynch syndrome-related mutations (eg, MLH1, MSH2, MSH6 ) are also advised to start at age 35 years if surgery is postponed. Learn more about breast cancer risk factors. Although mucinous tumors can arise directly from the ovary, many are actually secondary cancers that have spread from other organs, most notably the gastrointestinal system, including the colon and appendix. Distinguishing between primary and metastatic mucinous tumors is crucial for proper diagnosis and management. High-grade serous cancers more commonly begin in the epithelium of the fallopian tubes rather than the ovaries. On the other hand, low-grade serous carcinomas are thought to originate in the ovary and are typically diagnosed in younger females, with outcomes generally more favorable than their high-grade counterparts. Germ cell tumors and sex cord-stromal tumors are far more frequent in adolescents and young adults, with most cases occurring before age 30 years and not in women older than 45. Learn more about endometrioid carcinoma.
Entrepreneur
8 hours ago
- Entrepreneur
Entrepreneur UK's London 100: Numan
Numan is one of the UK's fastest-growing digital healthcare companies, redefining how patients approach their health through personalised, technology-driven solutions Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Industry: Healthtech Numan is one of the UK's fastest-growing digital healthcare companies, redefining how patients approach their health through personalised, technology-driven solutions. The company was founded in 2018 by Sokratis Papafloratos, an experienced entrepreneur with a track record of building and backing successful tech businesses. Numan began as a men's health startup focused on treating erectile dysfunction. In just six years, it has evolved into a full-scale digital healthcare provider, supporting over 500,000 patients through over 150 London-based staff with treatments for conditions like obesity, hair loss, and sexual health. The company generated £30m in revenue in 2023 and more than doubled that figure in 2024 – which was largely driven by the launch of their weight loss management service. The company recently launched its AI-powered Health Assistant, to support their holistic weight loss programme that includes GLP-1 prescribing. This proprietary tool is designed to provide real-time, personalised health guidance while ensuring rigorous safety and clinical oversight. With its rapid growth, technological advancements, and unwavering focus on safety and innovation, Numan is one of the most exciting and impactful London-based startups – deserving a place in the Entrepreneur UK London100 list as it continues to shape the future of digital health.
Entrepreneur
8 hours ago
- Entrepreneur
Entrepreneur UK's London 100: PERL Cosmetics
Industry: Health and Beauty By eliminating water, PERL Cosmetics offer a more potent, eco-conscious choice, redefining skincare with a commitment to natural, waterless beauty. Founded by Isobel Perl, the brand was born from her passion for science and love of skincare. With a focus on effective, sustainable, and skin-loving formulations, PERL Cosmetics delivers products free from unnecessary fillers and packed with pure, potent ingredients. Starting with a single product, a British Pink Clay Mask, this startup quickly gained traction through an engaged online community and word-of-mouth virality. They now boast a range of six skincare products with plans to double the range by 2026. £516,505.14 in revenue last year (2024), up 401% on 2023 A customer return rate of 11% 400,000+ social media followers, fueling an engaged community With bold ambition and an unwavering commitment to quality, PERL is a brand to watch, a business to celebrate, and a name that deserves a place among London's most innovative startups.
